Cas 946414-94-4 Nivolumab Monoclonal Antibodies For Breast Cancer
Cas 946414-94-4 Nivolumab Monoclonal Antibodies For Breast Cancer
| Product name:Nivolumab | Purity:99% min |
| CAS NO:946414-94-4 | Solubility:Soluble in DMSO |
| Molecular Formula:C6362H9862N1712O1995S42 | Package:Package according to customer requirements |
| Molecular Weight:143.6 kg/mol | Storage:Store at -20℃ |
Nivolumab is a medication used to treat cancer. It is used as a first line treatment for inoperable or metastatic melanoma in combination with ipilimumab if the cancer does not have a mutation in BRAF,as a second-line treatment following treatment with ipilimumab and if the cancer has a mutation in BRAF, with a BRAF inhibitor,[as a second-line treatment for squamous non-small cell lung cancer, and as a second-line treatment for renal cell carcinoma.
Related Products:
Alirocumab; Denosumab; Eculizumab; Evolocumab; Omalizumab; Ustekinumab; Vedolizumab; Trastuzumab; Omalizumab; Denosumab; Cetuximab; Bevacizumab; Aflibercept
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.